Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Neumora Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +31 vs. Q3 2024
- Shares held
- 80.3M
- +11.7M (+17.0%) vs. Q3 2024
- Total value
- $851.6M
- −$55.4M (−6.1%) vs. Q3 2024
- New holders
- 45
- 39 more added
- Sold out
- 14
- 31 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cerity Partners LLC | 243,908 | $2.59M | 0.01% | +1,008+0.4% | Added |
| Wexford Capital LP | 252,122 | $2.67M | 0.68% | +34,243+15.7% | Added |
| Millennium Management LLC | 257,430 | $2.73M | 0.00% | +257,430 | New |
| Soros Capital Management LLC | 279,333 | $2.96M | 0.46% | −229,580−45.1% | Reduced |
| Woodline Partners LP | 310,454 | $3.29M | 0.02% | +2,896+0.9% | Added |
| StemPoint Capital LP | 428,137 | $4.54M | 1.14% | +428,137 | New |
| Schonfeld Strategic Advisors LLC | 521,013 | $5.52M | 0.03% | +381,676+273.9% | Added |
| Candriam Luxembourg S.C.A. | 571,027 | $6.05M | 0.03% | −105,217−15.6% | Reduced |
| Callan Capital, LLC | 636,194 | $6.74M | 0.49% | −25,000−3.8% | Reduced |
| Sio Capital Management, LLC | 636,300 | $6.74M | 1.90% | +636,300 | New |
| Goldman Sachs Group Inc | 640,923 | $6.79M | 0.00% | +300,902+88.5% | Added |
| Charles Schwab Investment Management Inc | 704,154 | $7.46M | 0.00% | +5,899+0.8% | Added |
| Morgan Stanley | 731,412 | $7.75M | 0.00% | +377,721+106.8% | Added |
| Northern Trust Corp | 734,847 | $7.79M | 0.00% | +52,464+7.7% | Added |
| OrbiMed Advisors LLC | 804,996 | $8.53M | 0.18% | −695,004−46.3% | Reduced |
| Rock Springs Capital Management LP | 955,106 | $10.1M | 0.39% | +127,005+15.3% | Added |
| Baker Bros. Advisors LP | 1,034,600 | $11.0M | 0.12% | 00.0% | Unchanged |
| UBS Group AG | 1,241,945 | $13.2M | 0.00% | +902,274+265.6% | Added |
| JPMorgan Chase & Co | 1,399,717 | $14.8M | 0.00% | +1,335,296+2,072.8% | Added |
| Johnson & Johnson | 1,849,445 | $19.6M | 5.08% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,970,280 | $20.9M | 0.00% | −9,567−0.5% | Reduced |
| State Street Corp | 2,059,465 | $21.8M | 0.00% | +268,758+15.0% | Added |
| EcoR1 Capital, LLC | 2,071,450 | $22.0M | 0.88% | 00.0% | Unchanged |
| Lunate Holding RSC Ltd | 2,124,143 | $22.5M | 10.67% | +2,124,143 | New |
| ICONIQ Capital, LLC | 2,559,090 | $27.1M | 0.42% | −839,538−24.7% | Reduced |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,123 | $35.1M | 0.42% | 00.0% | Unchanged |
| Capital International Investors | 3,700,359 | $39.2M | 0.01% | +3,233,179+692.1% | Added |
| Deep Track Capital, LP | 4,000,000 | $42.4M | 1.59% | +3,432,572+604.9% | Added |
| Siren, L.L.C. | 4,396,100 | $46.6M | 2.06% | +1,789,529+68.7% | Added |
| MIC Capital Management UK LLP | 4,460,700 | $47.3M | 6.69% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,572,308 | $48.5M | 0.00% | +195,142+4.5% | Added |
| T. Rowe Price Investment Management, Inc. | 5,002,799 | $53.0M | 0.03% | −225,534−4.3% | Reduced |
| Softbank Group Corp | 6,541,190 | $69.3M | 0.30% | −1,005,726−13.3% | Reduced |
| BlackRock, Inc. | 7,106,996 | $75.3M | 0.00% | +920,102+14.9% | Added |
| FMR LLC | 7,838,577 | $83.1M | 0.00% | +89,421+1.2% | Added |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,800,000−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −432,996−100.0% | Sold out |
| Auour Investments LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −83,077−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −55,489−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −51,561−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −15,776−100.0% | Sold out |
| Ballentine Partners, LLC | 0 | $0 | 0.00% | −13,441−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,067−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,439−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −11−100.0% | Sold out |